Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Overcoming barriers to implementing new guideline-directed therapies for chronic kidney disease
Tang H, Donahoo WT, DeKosky ST, Lee YA, Kotecha P, Svensson M, Bian J, Guo J (2025) GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Consumers are set to pay between $245 and $350 per month for obesity drugs including Wegovy and Zepbound
Most people starting GLP-1 medications are focused on losing fat
US$ 26.01
US$ 20.06
US$ 27.32
US$ 21.44
US$ 24.62
US$ 20.04
US$ 24.68
US$ 20.37
US$ 26.65
US$ 20.74
US$ 25.03
US$ 27.01
